These data were first presented by Nakul Ganju, MD, of Howard University Hospital, Washington, DC, at the 2026 Crohns and Colitis Congress on Friday, January 23, 2026, in Las Vegas, Nevada
Some formulations combine precursor and direct glutathione support
They are frequently combined with GLP-1 therapy or hormone optimization for synergistic metabolic benefit
An MTHFR variant does not directly measure current SAM, SAH, methylation capacity, oxidative stress, glutathione status or mitochondrial function
Response times vary considerably based on injury severity, chronicity, individual healing capacity, and product quality